Publication: 3322

Publication: 3322

β2-adrenergic receptor gene expression as a prognostic and predictive biomarker in HER2-positive early-stage breast cancer patients enrolled in the NCCTG-N9831 (Alliance) trial

DOI

URL

Google Scholar

Citation:: Annals of Oncology vol 31 (Supplement 4) S310

Meeting Instance:: ESMO 2020
Year:: 2020
Type:: Abstract
Sub type:: Poster General
Funding:: NCTN
Endpoint:: Secondary-not-in-original
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No

Parents:: None
Children:: 3323 3713

Program:: OGC
Primary Committee:: Breast
Sec. Committees:

Pharmas:: Genentech, Genomic Health
Grants:: : U10CA180821, U10CA180882, U24CA196171

Corr. Author:
Authors:: Rafael Caparica Yaohua Ma Claudia De Angelis François Richard Christine Desmedt Ahmad Awada Martine Piccart Edith A. Perez Alvaro Moreno-Aspitia Sunil Badve E. Aubrey Thompson Evandro de Azambuja

Networks:

Study: NCCTG-N9831
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: